Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling
about
Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their DerivativesSynergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A ReviewTocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.Pharmacological potential of tocotrienols: a review.Unleashing the untold and misunderstood observations on vitamin E.Gamma-tocotrienol and hydroxy-chavicol synergistically inhibits growth and induces apoptosis of human glioma cells.Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Celecoxib Treatment.Metabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cellsTocotrienols and breast cancer: the evidence to date.Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment.Chronic inflammation in cancer development.Mechanisms Mediating the Effects of γ-Tocotrienol When Used in Combination with PPARγ Agonists or Antagonists on MCF-7 and MDA-MB-231 Breast Cancer CellsSynergistic Antiproliferative Effects of Combined γ -Tocotrienol and PPAR γ Antagonist Treatment Are Mediated through PPAR γ -Independent Mechanisms in Breast Cancer Cells.Role of NF-kappaB in the anti-inflammatory effects of tocotrienols.Potential role of tocotrienols in the treatment and prevention of breast cancer.γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.γ-Tocotrienol and 6-Gingerol in Combination Synergistically Induce Cytotoxicity and Apoptosis in HT-29 and SW837 Human Colorectal Cancer Cells.Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells.COX-2-independent induction of apoptosis by celecoxib and polyamine naphthalimide conjugate mediated by polyamine depression in colorectal cancer cell lines.Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation.Induction of cellular and molecular Immunomodulatory pathways by vitamin E and vitamin C.Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma.Effect of PEG surface conformation on anticancer activity and blood circulation of nanoemulsions loaded with tocotrienol-rich fraction of palm oil.Development of Colorectal-Targeted Dietary Supplement Tablets Containing Natural Purple Rice Bran Oil as a Colorectal Chemopreventive.Synergistic Apoptotic Effects of Tocotrienol Isomers and Acalypha wilkesiana on A549 and U87MG Cancer Cells.
P2860
Q26824259-78F349B1-729F-4289-AC05-C795F8B631B0Q28074119-586DD8E8-00B0-4444-A0F0-ECB661A09191Q34209443-AA537100-4AF2-4C85-899E-56E9FFA7961DQ34268186-CD22F0BA-ADAB-4C60-8E95-FBF71AA86938Q34450166-03512BBC-9A0B-45E5-B955-5A86F9AFB6F5Q34581614-D81915C9-759A-49ED-87D1-8731F4B03E8EQ35198623-D502908E-1861-44A5-95CA-9AE35D1FDE9FQ35581635-55B16DE1-337F-402C-BEB4-934EF33071EDQ35648909-83C05B03-78E5-407B-9534-87385BA486BEQ35648930-8134D0EA-ED36-455A-B0A7-B6C8C715279FQ35648936-1206BDB0-AA04-460D-B6B7-8556AFF35050Q35928265-61C1AFA9-71E8-4119-ABF1-F53D58C40F90Q36602967-720F9579-8A71-4806-B689-FFEFD80E10B0Q37651124-A3782149-F74C-452F-9A5F-7525DB70DC02Q37786156-9C6CC5FB-BF7D-4451-8496-B6C27751D284Q38117310-D232373B-2579-4620-9E62-C458C27FE6BFQ38763243-82716238-3ABB-4004-8A0E-1A8A191D1D83Q38867141-874CBD63-0E8B-4234-A70E-5646EDC2C46AQ39375782-13437652-01C3-4677-AD12-936190B653EAQ39429883-0F96D811-541A-451A-9F6B-FB4CC570D91CQ39539316-BD865C0A-68C8-4788-9328-0FCC94963A7EQ40047014-AC85D213-E46E-4BA1-AAFE-D46EA912D12CQ41107342-1B2B52EB-CF5E-45A9-8FA2-F7D07CA3AD9EQ42122956-4B791820-2339-4606-BFE7-F0C5F45FB8FCQ52607616-9B5B56FE-F126-489E-BBA5-03D2B44C86B0Q55038626-983D6E45-1E1E-476E-AA38-E1021468A02D
P2860
Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Synergistic anticancer effects ...... in Akt and NFkappaB signaling
@ast
Synergistic anticancer effects ...... in Akt and NFkappaB signaling
@en
type
label
Synergistic anticancer effects ...... in Akt and NFkappaB signaling
@ast
Synergistic anticancer effects ...... in Akt and NFkappaB signaling
@en
prefLabel
Synergistic anticancer effects ...... in Akt and NFkappaB signaling
@ast
Synergistic anticancer effects ...... in Akt and NFkappaB signaling
@en
P2860
P1476
Synergistic anticancer effects ...... in Akt and NFkappaB signaling
@en
P2093
Amit B Shirode
Paul W Sylvester
P2860
P304
P356
10.1016/J.BIOPHA.2009.09.018
P577
2009-11-14T00:00:00Z